Warner Biddle

Warner Biddle

Chief Executive OfficeratKyverna Therapeutics· In proxies 2024–2025

Pay in FY2025-88% from the year before · Kyverna Therapeutics stock +151.3% the same year

Warner Biddle was paid $1.8M in FY2025 (Dec), down 88%. Kyverna Therapeutics stock rose 151.3% that year.

Pay$100 in the stock at the end of FY24 → $251
Pay is from the Summary Compensation Table of each Kyverna Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Kyverna TherapeuticsPublic company · 2 yr
    • Chief Executive Officer2024 – Present · 2 yrStock in role -80%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?